• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

An Introduction to Idiopathic Pulmonary Fibrosis

Slideshow

What are the early warning signs and symptoms of IPF? Click through this concise overview of the disease and its differential diagnosis.

Related Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
Daily Dose: Coadministration of RSV and Influenza Vaccines / image credit: ©New Africa/AdobeStock

Daily Dose: Coadministration of RSV and Influenza Vaccines

December 8th 2023
Article

Your daily dose of the clinical news you may have missed.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Paxlovid Associated with Virologic Rebound in One in Five Patients with Severe COVID-19 Infection image credit paxlovid ©Mike Mareen / stock.adobe.com

Paxlovid Associated with Virologic Rebound in One in Five Patients with Severe COVID-19 Infection

November 16th 2023
Article

The finding implies the potential for virus transmission after initial recovery from the infection, according to study authors.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

Daily Dose: Variation in Post-ED Follow-Up Visits for Acute Bronchiolitis Across US States / image credit: ©New Africa/AdobeStock

Daily Dose: Variation in Post-ED Follow-Up Visits for Acute Bronchiolitis Across US States

November 6th 2023
Article

Your daily dose of the clinical news you may have missed.

The Global Burden of Asthma Prevalence on Specific Subgroups / image credit asthma concept ©Visual Generation/stock.adobe.com

Low Estimated Burden of Asthma in Low- and Middle-Income Countries Likely Reflects Underdiagnosis, Underreporting

November 6th 2023
Article

A new meta-analysis found prevalence of asthma higher in countries with better air quality, higher income status, and health care access.

© 2023 MJH Life Sciences

All rights reserved.